UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci

PLoS genetics, 2011-03, Vol.7 (3), p.e1002026-e1002026

2011

Volltextzugriff (PDF)

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism

Nature (London), 2015-12, Vol.528 (7582), p.418-421

2015

Volltextzugriff (PDF)

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

Nature genetics, 2012-10, Vol.44 (10), p.1126-1130

2012

Volltextzugriff (PDF)

Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines

Scientific data, 2017-03, Vol.4 (1), p.170033-170033, Article 170033

2017

Volltextzugriff (PDF)

Rare Variants in TP53 and Susceptibility to Neuroblastoma

JNCI : Journal of the National Cancer Institute, 2014-04, Vol.106 (4), p.dju047-dju047

2014

Volltextzugriff (PDF)

Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma risk

Nature communications, 2017-09, Vol.8 (1), p.569-7, Article 569

2017

Volltextzugriff (PDF)

Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma

PLoS genetics, 2017-05, Vol.13 (5), p.e1006787-e1006787

2017

Volltextzugriff (PDF)

Replication of Neuroblastoma SNP Association at the BARD1 Locus in African-Americans

Cancer epidemiology, biomarkers & prevention, 2012-04, Vol.21 (4), p.658-663

2012

Volltextzugriff (PDF)

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

Nature genetics, 2009-06, Vol.41 (6), p.718-723

2009

Volltextzugriff (PDF)

Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines

Scientific data, 2017-12, Vol.4, p.170183-170183

2017

Volltextzugriff (PDF)

CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15), p.3155-3166

2015

Volltextzugriff (PDF)

MDB-96. CEREBROSPINAL FLUID LEVELS OF THE MIR216B-5P AS A MINIMALLY INVASIVE MONITORING TOOL FOR MEDULLOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Volltextzugriff (PDF)

The genetic landscape of high-risk neuroblastoma

Nature genetics, 2013-03, Vol.45 (3), p.279-284

2013

Volltextzugriff (PDF)

Common genetic variants in NEFL influence gene expression and neuroblastoma risk

Cancer research (Chicago, Ill.), 2014-12, Vol.74 (23), p.6913-6924

2014

Volltextzugriff (PDF)

Gene expression profiling during the transition to failure in TNF-α over-expressing mice demonstrates the development of autoimmune myocarditis

Journal of molecular and cellular cardiology, 2004-04, Vol.36 (4), p.515-530

2004

Volltextzugriff (PDF)

Abstract 690: Identifying the genetic basis of stage 4S neuroblastoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.690-690

2017

Volltextzugriff (PDF)

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

Nature (London), 2011-01, Vol.469 (7329), p.216-220

2011

Volltextzugriff (PDF)

Copy number variation at 1q21.1 associated with neuroblastoma

Nature (London), 2009-06, Vol.459 (7249), p.987-991

2009

Volltextzugriff (PDF)

Abstract 3000: Defining the subclonal landscape of high-risk neuroblastoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3000-3000

2017

Volltextzugriff (PDF)

Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma

JNCI : Journal of the National Cancer Institute, 2017-10, Vol.109 (10)

2017

Volltextzugriff (PDF)

Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8), p.2068-2078

2012

Volltextzugriff (PDF)

Abstract 5237: The long intergenic noncoding RNA LINC00340 is a neuroblastoma susceptibility gene

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5237-5237

2014

Volltextzugriff (PDF)

Abstract 3811: Rare variants at 16p11.2 and within TP53 influence neuroblastoma susceptibility

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3811-3811

2013

Volltextzugriff (PDF)

Abstract LB087: Characterization of JNJ-70218902, a TMEFF2 x CD3 bispecific antibody, in prostate cancer models

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.LB087-LB087

2022

Volltextzugriff (PDF)

Abstract A27: A noncoding polymorphism in a GATA-containing enhancer element drives the association of LMO1 with neuroblastoma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (20_Supplement), p.A27-A27

2014

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(96)
Bücher
(2)

Sprache

Englisch
(98)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Humans
(42)
Life Sciences & Biomedicine
(33)
Oncology
(20)
Neuroblastoma - Genetics
(16)
Genetic Aspects
(12)
Multiple Myeloma
(12)
Cancer
(11)
Hematology
(11)
Multiple Myeloma - Genetics
(11)
Genome-Wide Association Study
(10)
Genomes
(10)
Genomics
(10)
Male
(10)
Multidisciplinary Sciences
(10)
Multiple Myeloma - Pathology
(10)
Mutation
(10)
Neuroblastoma
(10)
Polymorphism, Single Nucleotide
(10)
Science & Technology - Other Topics
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma

Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines

Rare Variants in TP53 and Susceptibility to Neuroblastoma

Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma risk

Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma

Replication of Neuroblastoma SNP Association at the BARD1 Locus in African-Americans

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines

CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus

MDB-96. CEREBROSPINAL FLUID LEVELS OF THE MIR216B-5P AS A MINIMALLY INVASIVE MONITORING TOOL FOR MEDULLOBLASTOMA

The genetic landscape of high-risk neuroblastoma

Common genetic variants in NEFL influence gene expression and neuroblastoma risk

Gene expression profiling during the transition to failure in TNF-α over-expressing mice demonstrates the development of autoimmune myocarditis

Abstract 690: Identifying the genetic basis of stage 4S neuroblastoma

Integrative genomics identifies LMO1 as a neuroblastoma oncogene

Copy number variation at 1q21.1 associated with neuroblastoma

Abstract 3000: Defining the subclonal landscape of high-risk neuroblastoma

Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma

Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity

Abstract 5237: The long intergenic noncoding RNA LINC00340 is a neuroblastoma susceptibility gene

Abstract 3811: Rare variants at 16p11.2 and within TP53 influence neuroblastoma susceptibility

Abstract LB087: Characterization of JNJ-70218902, a TMEFF2 x CD3 bispecific antibody, in prostate cancer models

Abstract A27: A noncoding polymorphism in a GATA-containing enhancer element drives the association of LMO1 with neuroblastoma

Suchergebnisse filtern